These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8604168)

  • 1. Clozapine for treatment of schizophrenia.
    Orr RD
    JAMA; 1996 Jan; 275(3):186-7. PubMed ID: 8604168
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine. A novel antipsychotic agent.
    Baldessarini RJ; Frankenburg FR
    N Engl J Med; 1991 Mar; 324(11):746-54. PubMed ID: 1671793
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in CNS Drugs. Recent advances and considerations in the treatment of schizophrenia.
    J Clin Psychiatry; 1996 Jul; 57(7):315-26. PubMed ID: 8666580
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine: a comparison with other novel antipsychotics.
    Fleischhacker WW
    J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
    Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
    Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.
    Harvey PD; Sacchetti E; Galluzzo A; Romeo F; Gorini B; Bilder RM; Loebel AD
    Schizophr Res; 2008 Oct; 105(1-3):138-43. PubMed ID: 18077136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.
    Freudenreich O; Henderson DC; Walsh JP; Culhane MA; Goff DC
    Schizophr Res; 2007 May; 92(1-3):90-4. PubMed ID: 17321111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.
    de Lucena D; Fernandes BS; Kunz M; Fries GR; Stertz L; Aguiar B; Pfaffenseller B; Gama CS
    J Clin Psychiatry; 2010 Jan; 71(1):91-2. PubMed ID: 20129011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clozapine].
    Inada K; Ishigooka J
    Nihon Rinsho; 2013 Apr; 71(4):678-83. PubMed ID: 23678599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.
    Veerman SR; Schulte PF; Begemann MJ; de Haan L
    Pharmacopsychiatry; 2014 Nov; 47(7):231-8. PubMed ID: 25121994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine versus chlorpromazine in geriatric patients.
    Honigfeld G
    J Clin Psychiatry; 2000 Jan; 61(1):63-4. PubMed ID: 10695651
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Di Nardo F; Santoro V; Spina E; Zoccali RA
    Schizophr Res; 2011 Apr; 127(1-3):93-9. PubMed ID: 21262565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clozapine and risperidone.
    Hamer RM; Simpson PM
    Am J Psychiatry; 2000 Feb; 157(2):310. PubMed ID: 10671435
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?
    Taylor DM
    CNS Drugs; 2017 Mar; 31(3):177-180. PubMed ID: 28258419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.